Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Vaccine|January 18, 2011
Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pigDavid I Bernstein, Julie D Earwood, Fernando J Bravo, et al.Plos Pathogens|May 24, 2018
Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigsLauren M Hook, Tina M Cairns, Sita Awasthi, et al.Plos Pathogens|October 8, 2011
Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1Paolo Di Giovine, Ethan C Settembre, Arjun K Bhargava, et al.Molecular Therapy. Methods & Clinical Development|February 12, 2020
Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing AntibodiesCeren Tuzmen, Tina M Cairns, Doina Atanasiu, et al.The EMBO Journal|November 18, 2005
Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entryClaude Krummenacher, Vinit M Supekar, J Charles Whitbeck, et al.Journal of Virology|June 26, 2015
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type SpecificTina M Cairns, Zhen-Yu Huang, John R Gallagher, et al.Journal of Virology|February 3, 2007
Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regionsFlorent C Bender, Minu Samanta, Ekaterina E Heldwein, et al.Journal of Virology|April 29, 2005
Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5RLydia Aldaz-Carroll, J Charles Whitbeck, Manuel Ponce de Leon, et al.Nature Microbiology|June 10, 2026
Immunogenicity of poxvirus A16/G9 entry-fusion subcomplex and its restriction by A56/K2 protein informs vaccine designHuibin Yu, Wolfgang Resch, Catherine A Cotter, et al.Journal of Virology|August 21, 2002
Herpes simplex virus type 1 evades the effects of antibody and complement in vivoJohn M Lubinski, Ming Jiang, Lauren Hook, et al.Pageof 12